Exploring Myositis-Associated Antibodies and Jack Inhibitors in Autoimmune Diseases

Exploring the impact of MDA5 antibodies on mortality in myositis patients, specifically its association with rapidly progressive lung diseases and severe skin findings. Insights from a study on dermatomyositis patients highlight high mortality rates linked to respiratory failure and the potential of jack inhibitors in improving survival and achieving remission.